HLL Lifecare Pays Record ₹69.53 Crore Dividend to Government for FY25

HLL Lifecare Limited, a Mini-Ratna Central Public Sector Enterprise (CPSE) under the Ministry of Health & Family Welfare, has strengthened its financial track record by paying a record dividend of ₹69.53 crore to the Government of India for FY 2024–25. This marks one of the highest dividends ever paid by the company.

The dividend cheque was presented to Shri J.P. Nadda, Union Minister of Health & Family Welfare, by Dr. Anitha Thampi, Chairperson, HLL, in the presence of Smt. Anupriya Patel, Minister of State for Health & Family Welfare, and senior officials from the ministry and the company.

Minister Commends HLL’s Contribution to Healthcare

During the event, Shri J.P. Nadda commended HLL for its sustained performance and contribution to India’s healthcare ecosystem. He stated that HLL, along with its subsidiaries and Amrit Pharmacies, has played a crucial role in improving access to affordable medicines and medical services. Over the past decade, Amrit Pharmacies have benefited more than 6.7 crore people and helped save over ₹8,000 crore in out-of-pocket medical expenses.

Strong Financial Growth in FY25

HLL Lifecare reported a significant improvement in its financial performance during FY 2024–25. Revenue from operations reached ₹4,500 crore, up 20% from the previous year, while the company’s net worth rose to ₹1,100 crore as of March 31, 2025. On a consolidated basis, including subsidiaries HITES, GAPL, and Lifespring Hospitals, the HLL Group achieved total revenue of ₹4,900 crore, reflecting 19% year-on-year growth.

Also Read: Tata Motors Demerger: When Can You Trade Tata Motors Commercial Vehicles Shares?

Background and Legacy

Established on March 1, 1966, HLL Lifecare has evolved from addressing India’s population control needs to becoming a comprehensive healthcare solutions provider. The company now operates across multiple product and service verticals, focusing on manufacturing, healthcare infrastructure, and affordable pharmacy initiatives such as AMRIT Pharmacies.

Conclusion

As HLL marks its 60th year, it continues to reinforce its mission of providing accessible, affordable, and quality healthcare to all. The company’s strong performance and record dividend payout underscore its pivotal role in supporting India’s public health goals and economic progress.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.